Other candidate treatment targets for non-infectious uveitis may be molecules involved in the IL-23R/Th17 pathway according to the susceptibility of IL-23R in BD, sarcoidosis, VKH disease, and AAU as previously described. This evidence concerns the gene IL23R and sarcoidosis.